Bridgeway Capital Management’s Aevi Genomic Medicine Inc GNMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
|
|||||
|
2019
Q1 | $44K | Hold |
|
|||||
|
2018
Q4 | $156K | Hold |
|
|||||
|
2018
Q3 | $275K | Buy |
|
|||||
|
2017
Q2 | – | Sell |
|
|||||
|
2017
Q1 | $349K | Hold |
|
|||||
|
2016
Q4 | $971K | Hold |
|
|||||
|
2016
Q3 | $1.04M | Buy |
|
|||||
|
2016
Q2 | $874K | Buy |
|
|||||
|
2016
Q1 | $524K | Hold |
|
|||||
|
2015
Q4 | $716K | Hold |
|
|||||
|
2015
Q3 | $931K | Hold |
|
|||||
|
2015
Q2 | $729K | Buy |
|
|||||
|
2015
Q1 | $636K | Buy |
|
|||||
|
2014
Q4 | $356K | Sell |
|
|||||
|
2014
Q3 | $415K | Hold |
|
|||||
|
2014
Q2 | $622K | Hold |
|
|||||
|
2014
Q1 | $558K | Buy |
|
|||||
|
2013
Q4 | $240K | Sell |
|
|||||
|
2013
Q3 | $541K | Buy |
|
|||||
|
2013
Q2 | $207K | Buy |
|